Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Clinical trial NCT04786067 · COMPLETED
Trial details
- NCT number
- NCT04786067
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2025-07-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.